DYADIC INTERNATIONAL INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
DYADIC INTERNATIONAL INC (DYAI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $3.58 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-03-25
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $3.58K.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2025-01-01: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $655.58K.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $655.58K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-09-30 | $3.58K 10-Q · filed 2025-11-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2025-01-01 | $655.58K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $655.58K 10-K · filed 2026-03-25 |
| 2024-09-30 | $3.50K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $138.36K 10-Q · filed 2024-08-13 |
| 2024-01-01 | $322.74K 10-Q · filed 2024-11-12 |
| 2023-12-31 | $322.74K 10-K · filed 2026-03-25 |
| 2023-09-30 | $987.33K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.01M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $642.79K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $13.00K 10-K · filed 2025-03-26 |
| 2022-09-30 | $770.54K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.11M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $3.93M 10-Q · filed 2022-05-12 |
| 2022-01-01 | $8.41M 10-K · filed 2024-03-28 |
| 2021-12-31 | $8.41M 10-K · filed 2023-03-29 |
| 2021-09-30 | $12.54M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.97M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $14.21M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $13.70M 10-K · filed 2023-03-29 |
| 2020-09-30 | $23.87M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $28.94M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $13.02M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $13.29M 10-K · filed 2022-03-29 |
| 2019-09-30 | $17.56M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $18.53M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $7.32M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.15M 10-K · filed 2021-03-30 |
| 2017-12-31 | $69.09K 10-K · filed 2020-03-30 |
| 2016-12-31 | $214.88K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |